Status of estrogen and progesterone receptors in various phases of the menstrual cycle in breast cancer

Archives of Iranian Medicine

Volumn 9, Issue 3, 2006, Pages 250-253

  Vasie, Mohammad ^a   Azarpira, Negar ^b   Talei, Abdolrasoul ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Estrogen receptor; Menstrual phase; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; PARAFFIN; POLYCLONAL ANTIBODY; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL ASSESSMENT; MENSTRUAL CYCLE; PREMENOPAUSE; PROTEIN EXPRESSION; TIME;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MASTECTOMY; MENSTRUAL CYCLE; MIDDLE AGED; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 33746398838     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS Jr. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol. 1981; 104: 23-34.
2. Ricketts D, Turnbull L, Ryall G, Bakhshi R, Rawson NS, Gazet JC, et al. Estrogen and progesterone receptors in the normal female breast. Cancer Res. 1991; 51: 1817-1822.
3. Silva JS, Georgiade GS, Dilley WG, McCarty KS Sr, Wells SA Jr, McCarty KS Jr. et al. Menstrual cycle-dependent variations of breast cyst fluid proteins and sex steroid receptors in the normal human breast. Cancer. 1983; 51: 1297-1302.
4. Gompel A, Martin A, Simon P, Schoevaert D, Plu-Bureau G, Hugol D, et al. Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle. Breast Cancer Res Treat. 1996; 38: 227-235.
5. Soderqvist G, Isaksson E, von Schoultz B, Carlstrom K, Tani E, Skoog L. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol. 1997; 176: 123-128.
6. Wilking N, Rutqvist LE, Nordenskjold B, Skoog L. Steroid receptor levels in breast cancer. Relationships with age and menopausal status. Acta Oncol. 1989; 28: 807-810.
7. Pujol P, Daures JP, Thezenas S, Guilleux F, Rouanet P, Grenier J. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause. Cancer. 1998; 83: 698-705.
8. Bergeron C, Ferenczy A, Toft DO, Shyamala G. Immunocytochemical study of progesterone receptors in the human endometrium during the menstrual cycle. Lab Invest. 1988; 59: 862-869.
9. Garcia E, Bouchard P, De Brux J, Berdah J, Frydman R, Schaison G, et al. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab. 1988; 67: 80-87.
10. Coradini D, Cappelletti V, Miodini P, Ronchi E, Scavone G, Di Fronzo G. Variations in estrogen and progesterone receptor content in premenopausal breast cancer patients throughout the menstrual cycle. Tumori. 1984; 70: 339-344.
11. Saez S, Martin PM, Chouvet CD. Estradiol and progesterone receptor level in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels. Cancer Res. 1978: 38: 3468-3473.
12. Weimer DA, Donegan WL. Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle. Breast Cancer Res Treat. 1987; 10: 273-278.
13. Markopoulos C, Berger U, Wilson P, Gazet JC, Coombes RC. Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Br Med J (Clin Res Ed). 1988; 296: 1349-1351.
14. Axelrod DM, Menendez-Botet CJ, Kinne DW, Osborne MP. Levels of estrogen and progesterone receptor proteins in patients with breast cancer during various phases of the menses. Cancer Invest. 1988; 6: 7-14.
15. Mangia A, De Lena M, Barletta A, Marzullo F, Attolico M, Stea B, et al. Timing of breast cancer surgery within the menstrual cycle: tumor proliferative activity, receptor status, and short-term clinical outcome. J Exp Clin Cancer Res. 1998; 17: 317-323.
16. Cooper LS, Gillett CE, Patel NK, Barnes DM, Fentiman IS. Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor. Cancer. 1999; 86: 2053-2058.
17. Atalay C, Kanlioz M, Altinok M. Menstrual cycle and hormone receptor status in breast cancer patients. Neoplasma. 2002; 49: 278.
18. Helin H, Isola J, Helle M, Koivula T. Discordant results between radioligand and immunohistochemical assays for steroid receptors in breast carcinoma. Br J Cancer. 1990; 62: 109-112.
19. Holli K, Isola J, Hakama M. Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient - fact or fallacy. Br J Cancer. 1995; 71: 124-127.
20. Badwe RA, Juvekar RR. Timing of breast cancer surgery during the menstrual cycle. Ann Oncol. 1994; 5: 29-31.
21. Lester SC. The Breast. In: Kumar V, Abbas AK, Fausto N, eds. Pathologic Basis of Diseases. 17th ed. Philadelphia: Elsevier Saunders; 2005: 1119-1154.